pCAG-luciferase Citations (7)

Originally described in: Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.
Lee YH, Andersen JB, Song HT, Judge AD, Seo D, Ishikawa T, Marquardt JU, Kitade M, Durkin ME, Raggi C, Woo HG, Conner EA, Avital I, Maclachlan I, Factor VM, Thorgeirsson SS Cancer Res. 2010 Nov 1;70(21):8264-9. doi: 10.1158/0008-5472.CAN-10-0749. Epub 2010 Oct 19. PubMed Journal

---

Articles Citing pCAG-luciferase

Articles
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas. Bharambe HS, Paul R, Panwalkar P, Jalali R, Sridhar E, Gupta T, Moiyadi A, Shetty P, Kazi S, Deogharkar A, Masurkar S, Yogi K, Kunder R, Gadewal N, Goel A, Goel N, Chinnaswamy G, Ramaswamy V, Shirsat NV. Acta Neuropathol Commun. 2019 Apr 3;7(1):52. doi: 10.1186/s40478-019-0697-3. PubMed
Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma. Bharambe HS, Joshi A, Yogi K, Kazi S, Shirsat NV. Acta Neuropathol Commun. 2020 May 14;8(1):70. doi: 10.1186/s40478-020-00942-5. PubMed
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma. Colyn L, Barcena-Varela M, Alvarez-Sola G, Latasa MU, Uriarte I, Santamaria E, Herranz JM, Santos-Laso A, Arechederra M, Ruiz de Gauna M, Aspichueta P, Canale M, Casadei-Gardini A, Francesconi M, Carotti S, Morini S, Nelson LJ, Iraburu MJ, Chen C, Sangro B, Marin JJG, Martinez-Chantar ML, Banales JM, Arnes-Benito R, Huch M, Patino JM, Dar AA, Nosrati M, Oyarzabal J, Prosper F, Urman J, Cubero FJ, Trautwein C, Berasain C, Fernandez-Barrena MG, Avila MA. Hepatology. 2021 Jun;73(6):2380-2396. doi: 10.1002/hep.31642. PubMed
Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses. Yarovaya OI, Shcherbakov DN, Borisevich SS, Sokolova AS, Gureev MA, Khamitov EM, Rudometova NB, Zybkina AV, Mordvinova ED, Zaykovskaya AV, Rogachev AD, Pyankov OV, Maksyutov RA, Salakhutdinov NF. Viruses. 2022 Jun 14;14(6). pii: v14061295. doi: 10.3390/v14061295. PubMed
(+)-Usnic Acid and Its Derivatives as Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses. Filimonov AS, Yarovaya OI, Zaykovskaya AV, Rudometova NB, Shcherbakov DN, Chirkova VY, Baev DS, Borisevich SS, Luzina OA, Pyankov OV, Maksyutov RA, Salakhutdinov NF. Viruses. 2022 Sep 29;14(10):2154. doi: 10.3390/v14102154. PubMed
siRNA treatment targeting integrin alpha11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression. Chaudhary P, Yadav K, Lee HJ, Kang KW, Mo J, Kim JA. Breast Cancer Res. 2024 Apr 25;26(1):72. doi: 10.1186/s13058-024-01827-4. PubMed
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis. Mei M, Cupic A, Miorin L, Ye C, Cagatay T, Zhang K, Patel K, Wilson N, McDonald WH, Crossland NA, Lo M, Rutkowska M, Aslam S, Mena I, Martinez-Sobrido L, Ren Y, Garcia-Sastre A, Fontoura BMA. Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2314166121. doi: 10.1073/pnas.2314166121. Epub 2024 May 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.